Greenwich Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $217K | Buy |
535
+2
| +0.4% | +$811 | 0.01% | 229 |
|
|
2025
Q1 | $265K | Sell |
533
-62
| -10% | -$30.8K | 0.02% | 206 |
|
|
2024
Q4 | $310K | Buy |
595
+64
| +12% | +$33.3K | 0.02% | 200 |
|
|
2024
Q3 | $329K | Hold |
531
| – | – | 0.02% | 196 |
|
|
2024
Q2 | $294K | Buy |
531
+3
| +0.6% | +$1.66K | 0.02% | 193 |
|
|
2024
Q1 | $307K | Buy |
528
+102
| +24% | +$59.3K | 0.02% | 189 |
|
|
2023
Q4 | $226K | Buy |
426
+13
| +3% | +$6.9K | 0.02% | 204 |
|
|
2023
Q3 | $209K | Sell |
413
-19
| -4% | -$9.62K | 0.02% | 206 |
|
|
2023
Q2 | $226K | Hold |
432
| – | – | 0.02% | 200 |
|
|
2023
Q1 | $249K | Buy |
432
+2
| +0.5% | +$1.15K | 0.03% | 196 |
|
|
2022
Q4 | $237K | Hold |
430
| – | – | 0.03% | 202 |
|
|
2022
Q3 | $218K | Buy |
+430
| New | +$218K | 0.02% | 208 |
|
|
2022
Q2 | – | Sell |
-370
| Closed | -$218K | – | 248 |
|
|
2022
Q1 | $218K | Buy |
370
+2
| +0.5% | +$1.18K | 0.02% | 215 |
|
|
2021
Q4 | $245K | Sell |
368
-65
| -15% | -$43.3K | 0.02% | 211 |
|
|
2021
Q3 | $248K | Sell |
433
-28
| -6% | -$16K | 0.02% | 209 |
|
|
2021
Q2 | $232K | Buy |
+461
| New | +$232K | 0.02% | 200 |
|